Correction: The novel Chinese medicine JY5 formula alleviates hepatic fibrosis by inhibiting the notch signaling pathway

A correction refers to a change to their article that the author wishes to publish after publication. The publication of this article is subject to Frontiers' editorial approval.Instructions:• Please read through all the templates before choosing • Pick the most relevant text template(s) from the following page and delete all others.• Edit the text as necessary, ensuring that the original incorrect text is included for the record, please see the below. • Please do not use any extra formatting when editing the templates, and only modify the red text unless absolutely necessary • Submit to Frontiers following the instructions on this page.When the original text contained incorrect information, to preserve the scientific record, please include that text when editing the below templates. For example:There was a mistake in the Funding statement, an incorrect number was used.The correct number is "2015C03Bd051.". The publisher apologizes for this mistake.The original version of this article has been updated. There was a mistake in Figure 4G as published. Figure 4G presents the Col-IV immunohistochemistry results. During data organization and figure preparation, a clerical oversight in file naming led to the image intended for the JY5 group being inadvertently replaced with that of the DAPT group. This error occurred purely by accident during figure assembly. This error affected only the final placement of the image; all quantitative analyses were performed using accurate, original data. Therefore, the correction does not alter any of the study's results, scientific conclusions, or data interpretations. The corrected Figure 4 Reminder: Figures, tables, and images will be published under a Creative Commons CC-BY license and permission must be obtained for use of copyrighted material from other sources (including re-published/adapted/modified/partial figures and images from the internet). It is the responsibility of the authors to acquire the licenses, to follow any citation instructions requested by third-party rights holders, and cover any supplementary charges.for a reason not seen here, please contact the journal's editorial office.